Genscript Biotech Reports LB2102 Solid Tumor Initial Human Study Results and CARVYKTI® Latest Data in Myeloma at 2026 ASCO

Stock News

06/01

Genscript Biotech Co., Ltd. has made an announcement. Its associate company Legend Biotech Corporation, which is listed on the NASDAQ Global Select Market in the form of American Depositary Shares, submitted a Form 6-K to the U.S. Securities and Exchange Commission on June 1, 2026, and issued a press release.

The release disclosed initial human trial data for its investigational DLL3-targeted CAR-T cell therapy, LB2102, in patients with relapsed or refractory small cell lung cancer or large cell neuroendocrine carcinoma.

It also presented the latest analyses from the CARTITUDE program.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1151129897"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151129897\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151129897?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 22:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151129897","market":"sg","top_or_hot":-1,"title":"Genscript Biotech Reports LB2102 Solid Tumor Initial Human Study Results and CARVYKTI® Latest Data in Myeloma at 2026 ASCO","media":"Stock News","content":"<p>Genscript Biotech Co., Ltd. has made an announcement. Its associate company Legend Biotech Corporation, which is listed on the NASDAQ Global Select Market in the form of American Depositary Shares, submitted a Form 6-K to the U.S. Securities and Exchange Commission on June 1, 2026, and issued a press release.<br><br>\nThe release disclosed initial human trial data for its investigational DLL3-targeted CAR-T cell therapy, LB2102, in patients with relapsed or refractory small cell lung cancer or large cell neuroendocrine carcinoma.<br><br>\nIt also presented the latest analyses from the CARTITUDE program.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genscript Biotech Reports LB2102 Solid Tumor Initial Human Study Results and CARVYKTI® Latest Data in Myeloma at 2026 ASCO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenscript Biotech Reports LB2102 Solid Tumor Initial Human Study Results and CARVYKTI® Latest Data in Myeloma at 2026 ASCO\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-06-01 22:56</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Genscript Biotech Co., Ltd. has made an announcement. Its associate company Legend Biotech Corporation, which is listed on the NASDAQ Global Select Market in the form of American Depositary Shares, submitted a Form 6-K to the U.S. Securities and Exchange Commission on June 1, 2026, and issued a press release.<br><br>\nThe release disclosed initial human trial data for its investigational DLL3-targeted CAR-T cell therapy, LB2102, in patients with relapsed or refractory small cell lung cancer or large cell neuroendocrine carcinoma.<br><br>\nIt also presented the latest analyses from the CARTITUDE program.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1141","symbol_name":"生命科學工具和服務","start_time":0,"source_url":"","article_id":"1151129897","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151129897","pubTimestamp":1780325780,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Genscript Biotech Co., Ltd. has made an announcement. Its associate company Legend Biotech Corporation, which is listed on the NASDAQ Global Select Market in the form of American Depositary Shares,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1141":"生命科学工具和服务","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","BK1583":"高瓴概念","BK1576":"医药外包概念","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC","01548":"金斯瑞生物科技","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC"},"translate_title":"金斯瑞生物报告LB2102实体瘤初始人体研究结果和CARVYKTI®2026年ASCO骨髓瘤最新数据","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"Genscript Biotech Co., Ltd. has made an announcement. Its associate company Legend Biotech Corporation, which is listed on the NASDAQ Global Select Market in the form of American Depositary Shares, submitted a Form 6-K to the U.S. Securities and Exchange Commission on June 1, 2026, and issued a press release.\nThe release disclosed initial human trial data for its investigational DLL3-targeted CAR-T cell therapy, LB2102, in patients with relapsed or refractory small cell lung cancer or large cell neuroendocrine carcinoma.\nIt also presented the latest analyses from the CARTITUDE program.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}